Management of liver disease patients in different clinical situations during COVID-19 pandemic
Review
[키워드] acute respiratory syndrome
Admission
Adults
Autoimmune
available data
basic
children
China
chronic
chronic liver disease
Chronic Liver Diseases
clearance
coronavirus
Course
COVID-19
COVID-19 infection
COVID-19 pandemic
decrease
deficiency
disease
drug
Evidence
Fatty liver
Follow-up
HBV
healthcare
healthcare worker
hemochromatosis
hepatitis B
hepatitis C
Hepatocellular carcinoma
Immunosuppression
immunosuppressive
increased risk
infected with COVID-19
Infection
infection with COVID-19
liver
Liver cirrhosis
Liver disease
liver diseases
liver enzyme
management
Mild
obese patient
Patient
patients
Personal protective equipment
poor prognosis
preliminary report
recipient
reported
SARS-CoV-2
severity
severity of COVID-19
Spread
Telemedicine
therapy
Viral hepatitis
Wilson’s disease
[DOI] 10.1186/s43066-021-00091-x PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s43066-021-00091-x PMC 바로가기 [Article Type] Review